search
Back to results

Development of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations (MVFL)

Primary Purpose

Vascular Malformations

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Focus Group
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Vascular Malformations focused on measuring low-flow vascular malformations, scale of life's quality

Eligibility Criteria

11 Years - 15 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Phase 1:

  • Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old.
  • Patient with slow-flow vascular malformation, whatever its clinical form, its severity (clinical and imaging diagnosis), aged over 15 years-old.
  • Parents of a patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old inclusive
  • Patient affiliated to a social security scheme
  • Patient having given his consent or for the minor whose legal representative has given written informed consent.

Phase 2 :

  • Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), 11 to 15 years-old of age included.
  • Patient affiliated to a social security scheme
  • Patient having given his consent or for the minor whose legal representative has given his informed consent

Exclusion criteria :

For both phases: Pregnant or lactating women or girls,

  • Vulnerable persons,
  • Majors subject to a legal protection measure or unable to express their consent Phase 1: Patient or parent who does not speak the French language and therefore are unable to express themselves in the focus groups.
  • Patient under 11 years-old; Phase 2 : Patient who does not speak French and is therefore unable to complete quality of life questionnaires
  • Patient under 11 or over 15 years-old.

Sites / Locations

  • UHBordeaux
  • UHChambrayRecruiting
  • UHNantes

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Child with slow-flow malformation

Arm Description

Phase 1: Collect of experiences, perceptions, difficulties, needs and expectations of patients with slow-flow vascular malformation (for the age group of 11 to 15 years-old) using the focus group method. Phase 2 : Administration of the scale of life's quality for validation.

Outcomes

Primary Outcome Measures

Specific scale of life's quality for slow-flow vascular malformation
Specific scale of life's quality for slow-flow vascular malformation. the preliminary version of which is created by transforming the qualitative categories resulting from the qualitative analysis of the verbatim into an exhaustive list of thematic items which will then be selected and sorted by the experts and whose final version is obtained by the statistical validation analysis aimed at structural validity and unidimensionality and convergent and discriminant validity.

Secondary Outcome Measures

Full Information

First Posted
February 14, 2018
Last Updated
March 2, 2018
Sponsor
University Hospital, Toulouse
search

1. Study Identification

Unique Protocol Identification Number
NCT03440827
Brief Title
Development of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations
Acronym
MVFL
Official Title
Development and Validation of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations Aged 11 to 15 Years-old.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2018
Overall Recruitment Status
Unknown status
Study Start Date
February 23, 2018 (Actual)
Primary Completion Date
February 2019 (Anticipated)
Study Completion Date
February 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The low-flow malformations include venous and lymphatic malformations. The malformation often affects the skin and can extend deep to the muscles and bone, as well as to deep organs. Children with low-flow vascular malformation and their family have difficulty living with their illness and have an impact on their life quality. In this context, the aim of the study is to develope life quality test for the children between 11 to 15 years old.
Detailed Description
The low-flow vascular malformations include venous and lymphatic malformations. These malformations are made of dilated dysplastic vessels in which the circulation is lowed down, which can lead to phenomena of thrombosis, hemorrhage, with sometimes a repercussion on the general coagulation. The malformation often affects the skin and can extend deep to the muscles and bone, as well as to deep organs. It presents by swelling sometimes voluminous and often painful. Children with low-flow malformations and their families have difficulty living with their illness and have an impact on their quality of life (QOL). These difficulties seem relative to : the lack of knowledge of the disease by doctors and the general public - medical difficulties directly related to the disease and its evolution: pain, deformation, biological anomaly, chronicity, lack of effective treatment psychological difficulties related to the visible and unesthetic appearance of the lesions excluding certain social activities The difficulties experienced by patients with slow-flow malformations and their family, as well as the impact on their QOL, have never been studied. Although QOL appears to be the best reflection of the severity of a chronic condition, there is no QOL questionnaire that is appropriate for the slow-flow malformations of the child or adult. The aim of the study is to develope a specific life quality test for children between 11 to 15 years old. These data will be used in a second time to build and validate a scale of quality of life specific slow-flow malformations of the child aged 11 to 15 years old. The study is build in 3 parts: Focus group: collect the dimension of the lived experience and the perceptions of the children with slow-flow malformations as well as their needs and their expectations Validation of the life quality test: the data obtained during focus group will be used to develop the scale of life quality specific to the child aged 11 to 15 years suffering to low-flow malformations. In a second time to validate the scale, this life quality test will be send to patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vascular Malformations
Keywords
low-flow vascular malformations, scale of life's quality

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Child with slow-flow malformation
Arm Type
Other
Arm Description
Phase 1: Collect of experiences, perceptions, difficulties, needs and expectations of patients with slow-flow vascular malformation (for the age group of 11 to 15 years-old) using the focus group method. Phase 2 : Administration of the scale of life's quality for validation.
Intervention Type
Behavioral
Intervention Name(s)
Focus Group
Intervention Description
First (phase 1), collect experiences, perceptions, difficulties, needs and expectations of patients with slow-flow malformations (for the age group of 11 to 15 years-old), carried out with 3 categories of participants and then (phase 2) development and validation of the specific scale of life's quality of slow-flow vascular malformation in children aged 11 to 15 years-old.
Primary Outcome Measure Information:
Title
Specific scale of life's quality for slow-flow vascular malformation
Description
Specific scale of life's quality for slow-flow vascular malformation. the preliminary version of which is created by transforming the qualitative categories resulting from the qualitative analysis of the verbatim into an exhaustive list of thematic items which will then be selected and sorted by the experts and whose final version is obtained by the statistical validation analysis aimed at structural validity and unidimensionality and convergent and discriminant validity.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
11 Years
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Phase 1: Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old. Patient with slow-flow vascular malformation, whatever its clinical form, its severity (clinical and imaging diagnosis), aged over 15 years-old. Parents of a patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), aged 11 to 15 years-old inclusive Patient affiliated to a social security scheme Patient having given his consent or for the minor whose legal representative has given written informed consent. Phase 2 : Patient with slow-flow vascular malformation, regardless of clinical form, severity (clinical and imaging diagnosis), 11 to 15 years-old of age included. Patient affiliated to a social security scheme Patient having given his consent or for the minor whose legal representative has given his informed consent Exclusion criteria : For both phases: Pregnant or lactating women or girls, Vulnerable persons, Majors subject to a legal protection measure or unable to express their consent Phase 1: Patient or parent who does not speak the French language and therefore are unable to express themselves in the focus groups. Patient under 11 years-old; Phase 2 : Patient who does not speak French and is therefore unable to complete quality of life questionnaires Patient under 11 or over 15 years-old.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Juliette Mazereeuw-Hautier, MD
Phone
5 67 77 81 41
Ext
33
Email
mazereeuw-hautier.j@chu-toulouse.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Isabelle OLIVIER, PhD
Phone
561777051
Ext
+33
Email
olivier.i@chu-toulouse.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juliette Mazereeuw-Hautier, MD
Organizational Affiliation
University Hospital, Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
UHBordeaux
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christine Leauté-Labrèze, MD
Phone
556795642
Ext
+33
Email
christine.labreze@chu-bordeaux.fr
Facility Name
UHChambray
City
Chambray-lès-Tours
ZIP/Postal Code
37170
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Annabel Maruani-Raphael, MD
Phone
247474625
Ext
+33
Email
annabel.maruani@univ-tours.fr
Facility Name
UHNantes
City
Nantes
ZIP/Postal Code
44093
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sébastien Barbarot, MD
Phone
240084086
Ext
+33
Email
sebastien.barbarot@chu-nantes.fr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Development of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations

We'll reach out to this number within 24 hrs